HBOT TREATMENT FOR
CHEST, BONE, LIMB, and SPINE RADIATION NECROSIS


Chest
Bone
Limb
Spinal Cord

    CHEST

    Radiation is used to treat lung, breast, and esophageal cancers. Chest wall radionecrosis occurs most frequently after mastectomy because of the need to treat skin and subcutaneous tissues—after breast cancer, tumors often recur in the skin of the chest wall. Hart reported that skin grafts succeeded for all six patients with radiation injury who were treated with HBOT after grafting. Feldmeier reported that six of eight with soft tissue necrosis and eight of fifteen with soft tissue and bone necrosis responded with full resolution. Those with bone necrosis required resection of non-viable bone.

    In 2001, Carl and Hartmann studied 44 patients with complications of early breast cancer lumpectomy and irradiation with fifteen 90-minute HBOT treatments at 2.4 ATA. Before treatment symptoms included pain, swelling (edema), thickening of tissue (fibrosis), and engorged capillaries (telengactasias). Of these patients, thirty-two agreed to undergo hyperbaric treatment; twelve refused. For those who were treated with HBOT, pain was markedly reduced, while seven had complete remission of symptoms by the end of the study. The control group experienced no improvement in pain or edema.

    Radiation treatment of chest and chest wall (most commonly lung and breast malignancies) often results in lung inflammation, pneumonia, and collapsed lung. Initial treatment reduces the level of surfactant, which keeps air passages open. Breathing can be difficult, with the individual suffering cough and shortness of breath.

    Radiation can also cause fibrosis, a stiffening or scarring of the lung which can restrict the full expansion required for breathing.

    Less common is actual tissue death, but lung cancer, and mesothelioma, a cancer of the tissue surrounding the lungs and most often seen in persons exposed to asbestos, may occur. Nerve damage to the larynx (voice box) or the diaphragm can also result from radiation treatment.

    Radiation-induced heart disease and arteriosclerosis are increasing in prevalence, as well as valve insufficiency, and muscle damage. Previous chemotherapy, total body irradiation, or concentrated administration adjacent to the heart or on the left side of the chest increase risks to the heart.

    
Study results for HBOT treatment were 75% resolution for soft tissue necrosis and 53% for bone necrosis, which included substantial healing after the removal of dead bone.

    
Post breast cancer radiation patients with persistent and intense pain experience significant relief with HBOT.

    Many of the effects of radiation treatment are not seen for years. It may be difficult to diagnose which symptoms are caused by recurrence of the tumor, metastasis (spreading of the original tumor to new sites), new malignant growths, or damage caused by the radiation so many years before.

    BONE

    Bone is almost twice as dense as soft tissues, and absorbs a larger amount of incident radiation than surrounding soft tissue. Radiation damages the bone cells, the ability of bone to build new white and red blood cells (a function of the marrow), and bone blood supply, as well as disrupting the constant normal process of bone resorption and building. When blood cell manufacture is disrupted, leukemia (blood or bone marrow cancer), hemorrhage (bleeding), or reduced resistance to infection can result. When more of the bone is destroyed than is built, the imbalance causes osteoporosis (thinning and weakening of the bones) and ultimately bone death (necrosis).

    Bone structures most frequently affected are:
         1) the lower jaw (because of its greater density and lesser blood supply) after head and neck radiation,
         2) the ribs, collar bone, and breastbone after breast cancer radiotherapy,
         3) the skull after treatment for brain and scalp tumors,
         4) the spinal column after radiation for spinal cord tumors, and
         5) the pelvis and head of the thigh bone following radiation of pelvic tumors.

    The incidence of secondary, radiation-induced cancers is decreasing due to the ability to provide more precise targeting and increased accuracy in choosing radiation dosage.
    
In the 1970s, the USAF developed an HBOT protocol for treatment of mandibular necrosis (death of the bone of the lower jaw), with an optimal sequencing of HBOT and surgery for per-surgical HBOT treatment. The success has been unparalleled. Subsequent studies showed a dramatic reduction in bone death when HBOT was used before dental extractions in highly at-risk patients.

    
In one study of radiation-induced lower jaw bone death, 83.6% of patients experienced significant improvement after HBOT.

    
When bone regeneration is required, an implant of healthy bone tissue may be needed to “jump start” healing.

    LIMB

    Hyperbaric oxygen treatment may be useful in the treatment of radiation necrosis of the extremities. Feldmeier published a series of reports detailing the experience of seventeen patients with extremity necrosis who were treated with hyperbaric oxygen. Eleven of seventeen had resolution of their symptoms.

    The extremities (arms and legs) may develop swelling long after radiation treatment. This is associated with damage to the lymph and circulatory systems, treatment-area specific scarring, and muscle atrophy.
    
Hyperbaric Oxygen Therapy (HBOT) has many of the same benefits for necrosis as it has for other wound-healing applications, reducing swelling and initiating and accelerating the growth of healthy tissue. In cases without recurrent cancer, up to 85% of treated patients had complete soft tissue necrosis resolution with HBOT.

    
For ulcers, HBOT stimulates collagen formation and enhances the development of new blood vessels into the previously oxygen-starved tissues, measurable after only 8 HBOT treatments. After 20 treatments, the development of new capillaries plateaus at 80 to 85% of that in unradiated tissue. HBOT has not shown benefits beyond the initial treatment.

    SPINAL CORD
Researcher Diagnosis # of Patients Treated with HBOT # Improved
Hart and Mainous Myelitis 5 0
Glassburn and Brady Myelitis 9 6
Calabro and Jinkins Transverse Myelitis 1 1

    Spinal cord symptoms may be the result of late effect radiation damage, or they can result from recurrent or spreading tumor. Radiation damage is a function of total radiation exposure and frequency of treatment. Leg motor function can be impaired, typically 2 to 25 years after treatment.

    
In 5 reports of 17 patients treated with HBOT, 100% showed improvement for radiation-induced neuropathy, with long term improvement present in 85%. Fontanesi’s unpublished study showed a 90% positive response rate. It appears that HBOT may be the only treatment capable of reversing brain radiation-induced neuropathy.

    
Investigation of the use of HBOT to reduce radiation-induced inflammation in the central nervous system is still under study. It has been show to be an important therapy for radiation induced swelling and neuropathy within the brain, as an adjunct to surgery and the use of corticosteroids.


©2008 Florida Oxygen